Biden claims vaccines will be available for all adults by the end of May — but there are caveats


President Biden delivered some exciting news Tuesday, promising the United States will have enough COVID-19 vaccine supply by the end of May for every American adult to get a shot.
Just a few weeks ago, Biden had set the end of July as the target date for universal availability, but the timeline has been expedited, largely thanks to the addition of the Johnson & Johnson vaccine to the arsenal. Biden couldn't account for the third shot when he last addressed the situation because it hadn't been granted emergency approval by the Food and Drug Administration at the time.
But that's where the caveats come in. Tuesday's announcement was primarily focused on an increase in supply, which is just one aspect of vaccine distribution. At least some of the hurdles that the U.S. currently faces in terms of actually getting people vaccinated could still be there in May. For example, Biden himself acknowledged that "it's not enough to have the vaccine supply, we need vaccinators — people to put the shots in people's arms," and, as Stat News points out, the president didn't highlight any new efforts to increase the number of vaccinators.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
That said, even though it's still unclear if every adult will actually be able to receive a vaccine by the end of May, the U.S. does appear to be consistently increasing its vaccination pace, so the supply increase may have come at the right time.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Film reviews: The Phoenician Scheme, Bring Her Back, and Jane Austen Wrecked My Life
Feature A despised mogul seeks a fresh triumph, orphaned siblings land with a nightmare foster mother, and a Jane fan finds herself in a love triangle
-
Music reviews: Tune-Yards and PinkPantheress
Feature "Better Dreaming" and "Fancy That"
-
Withdrawing 529 plan funds for college? Here's what to know.
the explainer Maximize the amount you have stashed away for your education
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows